<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Cloud-based platform</title>
    <description>
      <![CDATA[]]>
    </description>
    <link>https://www.bioworld.com/rss</link>
    <language>en-us</language>
    <item>
      <title>FDA gives nod to Respiree wearable for home care</title>
      <description>
        <![CDATA[The U.S. FDA cleared Respiree Pte. Ltd.’s 510(k) for its RS-001 cardio-respiratory wearable that measures respiration and offers passive cardio-respiratory monitoring.]]>
      </description>
      <guid>http://www.bioworld.com/articles/723580</guid>
      <pubDate>Fri, 05 Sep 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/723580-fda-gives-nod-to-respiree-wearable-for-home-care</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/Respiree-system-5sept25.webp?t=1757102252" type="image/jpeg" medium="image" fileSize="183808">
        <media:title type="plain">Respiree system</media:title>
      </media:content>
    </item>
    <item>
      <title>Sophia Genetics teases early data for AI lung cancer study</title>
      <description>
        <![CDATA[Sophia Genetics SA shared preliminary findings from its multimodal Deep-Lung-IV clinical study at the 2022 American Society of Clinical Oncology annual meeting. The study is utilizing Sophia’s cloud-based, artificial intelligence diagnostic platform to identify multimodal predictive signatures of response to immunotherapy for patients with advanced lung cancer.]]>
      </description>
      <guid>http://www.bioworld.com/articles/519522</guid>
      <pubDate>Tue, 07 Jun 2022 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/519522-sophia-genetics-teases-early-data-for-ai-lung-cancer-study</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Research-and-science/DNA-on-digital-background.webp?t=1610569805" type="image/png" medium="image" fileSize="553734">
        <media:title type="plain">DNA on digital background</media:title>
      </media:content>
    </item>
    <item>
      <title>Clinisys purchases cloud-based laboratory system Apollolims </title>
      <description>
        <![CDATA[Diagnostic testing group Clinisys Inc. has acquired cloud-based laboratory operations software company Apollolims in an undisclosed deal. Headquartered in Chertsey, U.K., and Tucson, Ariz., Clinisys will expand its public health, toxicology, and molecular diagnostics offering through the acquisition. The deal builds on the company’s combination with Sunquest and Horizon announced in January.]]>
      </description>
      <guid>http://www.bioworld.com/articles/517907</guid>
      <pubDate>Wed, 13 Apr 2022 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/517907-clinisys-purchases-cloud-based-laboratory-system-apollolims</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2022/04-13-Clinisys-Lab.webp?t=1649887672" type="image/png" medium="image" fileSize="1524278">
        <media:title type="plain">Woman working at computer in laboratory</media:title>
        <media:description type="plain">Credit: Clinisys Inc.
</media:description>
      </media:content>
    </item>
    <item>
      <title>Volpara acquires breast cancer risk assessment company CRA Health for $22M</title>
      <description>
        <![CDATA[PERTH, Australia &ndash; Wellington, New Zealand-headquartered Volpara Health Technologies Ltd. has acquired Boston-based CRA Health LLC for $18 million up front and an additional $4 million to be paid over the next 18 months in earnouts. Volpara&rsquo;s digital health solutions use imaging and artificial intelligence (AI) for early detection of breast cancer. The company&rsquo;s clinical functions for screening clinics provide feedback on breast density, compression, dose, and quality, while its enterprise-wide practice software management helps with productivity, compliance, reimbursement and patient tracking.]]>
      </description>
      <guid>http://www.bioworld.com/articles/503232</guid>
      <pubDate>Thu, 04 Feb 2021 13:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/503232-volpara-acquires-breast-cancer-risk-assessment-company-cra-health-for-22m</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Deals-and-MAs/Merger-puzzle-pieces-arrow-hands.webp?t=1644441920" type="image/png" medium="image" fileSize="99873">
        <media:title type="plain">Hands holding arrow-shaped puzzle pieces</media:title>
      </media:content>
    </item>
    <item>
      <title>Philips snags Capsule Technologies for $635M</title>
      <description>
        <![CDATA[Royal Philips NV will close on its $635 million acquisition of Capsule Technologies Inc. in the first quarter of 2021, continuing the expansion of the Dutch company&#39;s remote monitoring capabilities. Capsule&#39;s Medical Device Information Platform integrates nearly all medical devices used in hospitals with electronic health records in a vendor-neutral system. The deal has already received approval from the U.S. Federal Trade Commission and the Department of Justice.]]>
      </description>
      <guid>http://www.bioworld.com/articles/502562</guid>
      <pubDate>Tue, 19 Jan 2021 13:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/502562-philips-snags-capsule-technologies-for-635m</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Devices/connected-digital-health.webp?t=1589385444" type="image/png" medium="image" fileSize="397881">
        <media:title type="plain">Laptop, stethoscope, medical icons, health professional</media:title>
      </media:content>
    </item>
    <item>
      <title>Inheart raises $4.2M for launch of its cloud-based image analysis system for cardiac arrhythmia</title>
      <description>
        <![CDATA[PARIS &ndash; Inheart SAS completed its first funding round of $4.2 million to improve cardiac arrhythmia treatment using medical imaging, artificial intelligence and digital simulation. This fund round was led by Elvia Partners SAS, a Parisian investment fund managed by Xavier Lazarus specializing in deep tech, and Aquitaine Science Transfer, a company accelerating technology transfer, from the University of Bordeaux.]]>
      </description>
      <guid>http://www.bioworld.com/articles/477281</guid>
      <pubDate>Tue, 21 Jul 2020 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/477281-inheart-raises-42m-for-launch-of-its-cloud-based-image-analysis-system-for-cardiac-arrhythmia</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2020/7-21-Inheart.webp?t=1595368661" type="image/png" medium="image" fileSize="995871">
        <media:title type="plain">Inheart software</media:title>
        <media:description type="plain">The Inheart cloud-based modeling solution. Credit: Inheart SAS</media:description>
      </media:content>
    </item>
    <item>
      <title>Corvia launches Interatrial Shunt Device trial using Physiq's biosensor</title>
      <description>
        <![CDATA[Corvia Medical Inc. is enrolling patients in a 100-site multinational study of its Interatrial Shunt Device that will measure traditional heart failure endpoints as well as biosensor data transmitted to the cloud for analysis by Napier, Ill.-based Physiq's artificial intelligence analytics. The trial will evaluate Tewksbury, Mass.-based Corvia's device in heart failure with preserved and mid-range ejection fraction.]]>
      </description>
      <guid>http://www.bioworld.com/articles/430482</guid>
      <pubDate>Wed, 25 Sep 2019 00:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/430482-corvia-launches-interatrial-shunt-device-trial-using-physiqs-biosensor</link>
    </item>
    <item>
      <title>Cerner, Amazon deepen ties to get EHRs in the cloud and prepare for AI advances</title>
      <description>
        <![CDATA[Information technology and connectivity have transformed productivity and costs in nearly every industry. Health care, however, has remained persistently immune to this transmogrification. Electronic health records (EHRs) have been particularly disappointing on this front, with time-consuming and inconsistent physician data entry as well as poor integration across complex and emerging data sources from medical devices, imaging, genomics and wearables and, as a consequence, a lack of usefulness in improving population health analytics or personalized care.]]>
      </description>
      <guid>http://www.bioworld.com/articles/428448</guid>
      <pubDate>Wed, 07 Aug 2019 00:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/428448-cerner-amazon-deepen-ties-to-get-ehrs-in-the-cloud-and-prepare-for-ai-advances</link>
    </item>
  </channel>
</rss>
